179 related articles for article (PubMed ID: 26156586)
1. The effects and mechanisms of SLC34A2 in tumorigenesis and progression of human non-small cell lung cancer.
Wang Y; Yang W; Pu Q; Yang Y; Ye S; Ma Q; Ren J; Cao Z; Zhong G; Zhang X; Liu L; Zhu W
J Biomed Sci; 2015 Jul; 22(1):52. PubMed ID: 26156586
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-410 acts as oncogene in NSCLC through downregulating SLC34A2 via activating Wnt/β-catenin pathway.
Zhang X; Ke X; Pu Q; Yuan Y; Yang W; Luo X; Jiang Q; Hu X; Gong Y; Tang K; Su X; Liu L; Zhu W; Wei Y
Oncotarget; 2016 Mar; 7(12):14569-85. PubMed ID: 26910912
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of SLC34A2 inhibits cell proliferation, metastasis, and elevates chemosensitivity in glioma.
Bao Z; Chen L; Guo S
J Cell Biochem; 2019 Jun; 120(6):10205-10214. PubMed ID: 30592329
[TBL] [Abstract][Full Text] [Related]
4. The effects and mechanisms of SLC34A2 on tumorigenicity in human non-small cell lung cancer stem cells.
Jiang Z; Hao Y; Ding X; Zhang Z; Liu P; Wei X; Xi J
Tumour Biol; 2016 Aug; 37(8):10383-92. PubMed ID: 26846105
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of SLC34A2 inhibits the viability and invasion of A549 cells.
Yang W; Wang Y; Pu Q; Ye S; Ma Q; Ren J; Zhong G; Liu L; Zhu W
Mol Med Rep; 2014 Sep; 10(3):1205-14. PubMed ID: 25017204
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of SLC34A2 Inhibits Hepatocellular Carcinoma Cell Proliferation and Invasion.
Li Y; Chen X; Lu H
Oncol Res; 2016 Oct; 24(6):511-519. PubMed ID: 28281971
[TBL] [Abstract][Full Text] [Related]
7. SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms.
He J; Zhou M; Li X; Gu S; Cao Y; Xing T; Chen W; Chu C; Gu F; Zhou J; Jin Y; Ma J; Ma D; Zou Q
Oncogene; 2020 Mar; 39(13):2658-2675. PubMed ID: 32005974
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA MEG3 regulates migration and invasion of lung cancer stem cells via miR-650/SLC34A2 axis.
Zhao Y; Zhu Z; Shi S; Wang J; Li N
Biomed Pharmacother; 2019 Dec; 120():109457. PubMed ID: 31585300
[TBL] [Abstract][Full Text] [Related]
9. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of SLC34A2 is an independent prognostic indicator in bladder cancer and its depletion suppresses tumor growth via decreasing c-Myc expression and transcriptional activity.
Ye W; Chen C; Gao Y; Zheng ZS; Xu Y; Yun M; Weng HW; Xie D; Ye S; Zhang JX
Cell Death Dis; 2017 Feb; 8(2):e2581. PubMed ID: 28151475
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA F-circSR derived from SLC34A2-ROS1 fusion gene promotes cell migration in non-small cell lung cancer.
Wu K; Liao X; Gong Y; He J; Zhou JK; Tan S; Pu W; Huang C; Wei YQ; Peng Y
Mol Cancer; 2019 May; 18(1):98. PubMed ID: 31118036
[TBL] [Abstract][Full Text] [Related]
12. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
Yu SH; Zhang CL; Dong FS; Zhang YM
J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
[TBL] [Abstract][Full Text] [Related]
13. Highly expressed long non-coding RNA CRNDE promotes cell proliferation through PI3K/AKT signalling in non-small cell lung carcinoma.
Liu XX; Xiong HP; Huang JS; Qi K; Xu JJ
Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):895-902. PubMed ID: 28477368
[TBL] [Abstract][Full Text] [Related]
14. The effects and mechanisms of SLC34A2 on maintaining stem cell-like phenotypes in CD147
Lv Y; Wang T; Fan J; Zhang Z; Zhang J; Xu C; Li Y; Zhao G; He C; Meng H; Yang H; Wang Z; Liu J; Chen J; Wang L
Tumour Biol; 2017 Apr; 39(4):1010428317695927. PubMed ID: 28381172
[TBL] [Abstract][Full Text] [Related]
15. FAM83A is amplified and promotes tumorigenicity in non-small cell lung cancer via ERK and PI3K/Akt/mTOR pathways.
Hu H; Wang F; Wang M; Liu Y; Wu H; Chen X; Lin Q
Int J Med Sci; 2020; 17(6):807-814. PubMed ID: 32218702
[TBL] [Abstract][Full Text] [Related]
16. The high expression of MTH1 and NUDT5 promotes tumor metastasis and indicates a poor prognosis in patients with non-small-cell lung cancer.
Li DN; Yang CC; Li J; Ou Yang QG; Zeng LT; Fan GQ; Liu TH; Tian XY; Wang JJ; Zhang H; Dai DP; Cui J; Cai JP
Biochim Biophys Acta Mol Cell Res; 2021 Jan; 1868(1):118895. PubMed ID: 33096144
[TBL] [Abstract][Full Text] [Related]
17. Proliferating cell nuclear antigen promotes cell proliferation and tumorigenesis by up-regulating STAT3 in non-small cell lung cancer.
Wang L; Kong W; Liu B; Zhang X
Biomed Pharmacother; 2018 Aug; 104():595-602. PubMed ID: 29803172
[TBL] [Abstract][Full Text] [Related]
18. The oncogenic role of CB2 in the progression of non-small-cell lung cancer.
Xu S; Ma H; Bo Y; Shao M
Biomed Pharmacother; 2019 Sep; 117():109080. PubMed ID: 31176172
[TBL] [Abstract][Full Text] [Related]
19. MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway.
Zhao W; Sun Q; Yu Z; Mao S; Jin Y; Li J; Jiang Z; Zhang Y; Chen M; Chen P; Chen D; Xu H; Ding S; Yu Z
Gene; 2018 Sep; 670():31-37. PubMed ID: 29803922
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]